Sun Pharma Advanced Research Stock (NSE:SPARC)


INR 299.55
Today's Range
INR297.10 - INR305.85
52-Week Range
INR155.05 - INR349.00
Market Cap

About Sun Pharma Advanced Research (NSE:SPARC)

(NSE:SPARC) Sun Pharma Advanced Research Company Limited engages in the research and development of pharmaceutical products in India and internationally. The company develops new chemical entities or reformulated products based on its proprietary novel drug delivery systems. Its core therapeutic areas of interest include oncology, inflammation, and neurodegenerative diseases, as well as abuse deterrent formulations. The company offers Levetiracetam ER for epilepsy; and Xelpros eye drops for Glaucoma. It is also developing Taclantis for the treatment of cancer; salmeterol-fluticasone dry powder inhaler for use in asthma and COPD; Baclofen GRS for spasticity; Brimonidine OD for glaucoma and ocular hypertension; and SDN-037 steroid eye drops used for the treatment of pain and inflammation following ocular surgery, and other inflammatory ocular conditions. In addition, the company engages in the development of SCO-088, a Bcr?Abl kinase inhibitor for treatment resistant chronic myelogenous leukaemia (CML); SDN-021, an abuse deterrent formulation; and SCD-044, a S1P receptor-1 agonist, which uses lymphocyte trafficking to treat auto-immune disorders. Further, it develops SCC?138 for Parkinson's disease; SDN?118, a formulation for treating depression; SDD-098 to treat acne; and SDE-124, a sub cutaneous injection of GLP-1 receptor agonists, as well as SCO-125 to treat CML. Sun Pharma Advanced Research Company Limited has a collaboration agreement with Bioprojet to develop S1P receptor 1 agonist for autoimmune disorders; and HitGen to identify small molecule leads for targets of interest. The company was incorporated in 2006 and is based in Mumbai, India. Sun Pharma Advanced Research Company Limited is a subsidiary of Shanghvi Finance Pvt. Ltd.
Show more

SPARC Stock Price

Statistics Highlights (NSE:SPARC)

Shares Outstanding 271.88M Beta 1.01
Public Float 70.06M P/E Ratio -
% Short of Float - Dividend (Yield) -
Held by Insiders 76.52% Ex-Dividend Date
Held by Institutions 1.86% IPO Date -

SPARC Financial Summary

Mar 21 Mar 20 Mar 19
Revenue INR2.53B INR768.14M INR1.83B
EBITDA INR-1.30B INR-3.00B INR-1.38B
Net Income INR-1.51B INR-3.12B INR-1.45B
Total Assets INR2.30B INR2.73B INR3.98B
Total Cash INR93.05M INR3.52M INR3.50M
Total Debt INR2.36B INR683.45M INR16.36M
Dec 21 Sep 21 Jun 21
Revenue INR621.50M INR278.70M INR219.90M
EBITDA INR-109.30M INR-491.90M INR-534.70M
Net Income INR-158.40M INR-551.40M INR-613.70M
Total Assets INR INR2.96B INR
Total Cash INR INR582.50M INR
Total Debt INR INR1.55B INR

SPARC Stock Price History

Sun Pharma Advanced Research Annual Stock Price History

Year Open Close Change
2021 INR276.55 INR299.55 8.32%
2021 INR196.90 INR276.55 40.45%
2020 INR158.50 INR196.90 24.23%

Sun Pharma Advanced Research Daily Stock Price History

Date Open High Low Close Change Volume
Jun 17, 2022 INR185.40 INR190.00 INR170.45 INR185.15 -7.40% 760.40K
Jun 14, 2022 INR201.75 INR205.00 INR192.00 INR199.95 -7.11% 189.67K
Jun 9, 2022 INR211.95 INR216.30 INR210.65 INR215.25 -1.71% 119.83K

(NSE:SPARC) Stock Price FAQs

What is today's stock price of Sun Pharma Advanced Research (NSE:SPARC)?

  • The current stock price of Sun Pharma Advanced Research (NSE:SPARC) is INR299.55.
  • Today SPARC stock price opened at INR300.90 after previous close of INR299.20.
  • During the day, Sun Pharma Advanced Research stock quote has varied from a low of INR297.10 to a high of INR305.85.

What is Sun Pharma Advanced Research's 52-week change?

  • SPARC 52-week high stock quote is INR349.00, which is 16.50% above the current share price.
  • The Sun Pharma Advanced Research (NSE:SPARC) 52-week low stock price is INR155.05, which is 48.20% below the current share price.
  • Sun Pharma Advanced Research share price volatility (52-week beta) is 1.01.

Sun Pharma Advanced Research (NSE:SPARC) FAQ

How Much is Sun pharma advanced research Worth?

Sun pharma advanced research's worth today based on market capitalisation is INR82.01B

How much dividend does Sun pharma advanced research Pay?

The current annualized dividend payout for SPARC stock is INR0.00, the dividend yield is 0.00% and the payout ratio is 0.00%.
View More Details on Sun pharma advanced research's "Dividend" Section

When is the next earnings date for Sun pharma advanced research (NSE:SPARC)?

Sun pharma advanced research is expected to report earnings on July 25 ,2022.
View More Details on Sun pharma advanced research's 'Earnings' Section

What is Sun pharma advanced research’s Price to Earning (PE) ratio?

SPARC stock also has a Price to Sales (P/S) ratio of 58.55.

What is the Sun pharma advanced research's ticker?

Sun pharma advanced research trades on the NSE stock market in India under the ticker symbol "SPARC". Sun pharma advanced research’s stock symbol can also be displayed as "NSE:SPARC".

Who are the owners of Sun pharma advanced research?

Sun pharma advanced research (NSE:SPARC) is owned by 1.86% institutional shareholders and by 76.52% insiders. The rest is owned by the public.
Explore More Details on Sun pharma advanced research's “Ownership” Section

Who are the key executives of Sun pharma advanced research (SPARC)?

Sun pharma advanced research's key executive team includes the following managers:

  • Mr. Anilkumar Raghavan, Chief Exec. Officer (1969)
  • Mr. Chetan M. Rajpara, Chief Financial Officer (NA)
  • Mr. Siu-Long Yao, Exec. VP Clinical Devel. & Operations (NA)
  • Mr. Jaydeep Issrani, Sr. Gen. Mang. of Bus. Devel., Corp. Communication & Investor Relations (NA)
  • Mr. Dinesh Poosraj Lahoti, Company Sec. & Compliance Officer (NA)
  • Ms. Shanta Gupta, Chief Human Resource Officer (NA)
  • Dr. Subhas Bhowmick, Sr. VP (1956)
  • Dr. Trinadha Rao Chitturi, Sr. VP of R&D (1959)
  • Dr. Nitin Dharmadhikari, Exec. VP and Head Operational Excellence & COE's (1962)
  • Dr. Nitin K. Damle Ph.D., Sr. VP & Chief Innovation Officer (NA)

What is Sun pharma advanced research’s Sector & Industry Classification?

Sun pharma advanced research (NSE:SPARC) is classified under the "Healthcare" sector and under the "Drug Manufacturers-Specialty & Generic" industry.

How many employees work for Sun pharma advanced research?

Currently the number of employees working for Sun pharma advanced research is 410.

Where are Sun pharma advanced research's Headquarters?

Sun pharma advanced research (NSE:SPARC) is headquartered in India.

What are Sun pharma advanced research's Address and Phone Number?

Sun pharma advanced research’s mailing address is 17-B, Mahal Industrial Estate, Mumbai, India, 400093.
The company’s phone number is 91 22 6645 5645.

What is the official website for Sun pharma advanced research?

Sun pharma advanced research’s official website is